- To read more about “Glutaryl-CoA dehydrogenase deficiency”
- Genet Med . 2021 Jan;23(1):13-21.
(source: OrphaNews 10 May 2021)
Glutaryl-CoA dehydrogenase deficiency : a study showed that newborn screening programs for Glutaric aciduria type 1 have an overall positive effect on the neurological outcome but their success depends on the quality of therapy
Related news
Appropriate consent and health rights of children: Understanding the ethics of genomic newborn screening
A new article has been published in the European Journal of Human Gene...
Understanding the role of patient organisations in promoting and developing newborn screening
A new article has been published in Rare Disease and Orphan Drugs Jour...
The WHO/World Health Assembly adopts resolution concerning maternal, newborn and child mortality
The WHO/World Health Assembly adopts resolution A77/A/CONF./5 “A...
Dominican Republic moves to implement neonatal screening
Please see this link: https://dominicantoday.com/dr/health/2024/04/09/...
Methods for estimating rare disease prevalence
A new article has been published in Rare Disease and Orphan Drugs Jour...
New European Commission fact sheet on rare diseases
The European Commission has published a new fact sheet titled “EU Ac...